{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:08:48Z","timestamp":1775002128278,"version":"3.50.1"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T00:00:00Z","timestamp":1774569600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T00:00:00Z","timestamp":1774915200000},"content-version":"vor","delay-in-days":4,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-026-45597-9","type":"journal-article","created":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T05:43:37Z","timestamp":1774590217000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["The fluoroquinoline compound exerts anti-erythroleukemic effects by dual-targeting GLUT1 and the PI3K\/AKT signaling pathway"],"prefix":"10.1038","volume":"16","author":[{"given":"Sha","family":"Cheng","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Weijia","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jia","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xueling","family":"Meng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bixue","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ningning","family":"Zan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Baofei","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Heng","family":"Luo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,3,27]]},"reference":[{"key":"45597_CR1","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1182\/blood.2019003062","volume":"136","author":"A Fagnan","year":"2020","unstructured":"Fagnan, A. et al. Human erythroleukemia genetics and transcriptomes identify master transcription factors as functional disease drivers. Blood 136, 698\u2013714 (2020).","journal-title":"Blood"},{"key":"45597_CR2","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/j.blre.2017.09.002","volume":"32","author":"P Boddu","year":"2018","unstructured":"Boddu, P. et al. Erythroleukemia-historical perspectives and recent advances in diagnosis and management. Blood Rev. 32, 96\u2013105 (2018).","journal-title":"Blood Rev."},{"key":"45597_CR3","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1016\/j.clml.2023.04.011","volume":"23","author":"C Alexander","year":"2023","unstructured":"Alexander, C. A history and current understanding of acute erythroid leukemia. Clin. Lymphoma Myeloma Leuk. 23, 583\u2013588 (2023).","journal-title":"Clin. Lymphoma Myeloma Leuk."},{"key":"45597_CR4","doi-asserted-by":"publisher","first-page":"2614","DOI":"10.1038\/s41375-024-02394-5","volume":"38","author":"W Zhang","year":"2024","unstructured":"Zhang, W. et al. HDAC7 is a potential therapeutic target in acute erythroid leukemia. Leukemia 38, 2614\u20132627 (2024).","journal-title":"Leukemia"},{"key":"45597_CR5","doi-asserted-by":"publisher","first-page":"2391","DOI":"10.1182\/blood-2016-03-643544","volume":"127","author":"DA Arber","year":"2016","unstructured":"Arber, D. A. et al. The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia. Blood 127, 2391\u20132405 (2016).","journal-title":"Blood"},{"key":"45597_CR6","doi-asserted-by":"publisher","first-page":"1261","DOI":"10.5858\/2009-0350-RA.1","volume":"134","author":"Z Zuo","year":"2010","unstructured":"Zuo, Z. et al. Acute erythroid leukemia. Arch. Pathol. Lab. Med. 134, 1261\u20131270 (2010).","journal-title":"Arch. Pathol. Lab. Med."},{"key":"45597_CR7","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1016\/j.bjhh.2014.05.006","volume":"36","author":"GC De Santis","year":"2014","unstructured":"De Santis, G. C. et al. Pathologic rupture of the spleen in a patient with acute myelogenous leukemia and leukostasis. Rev. Bras. Hematol. Hemoter. 36, 290\u2013292 (2014).","journal-title":"Rev. Bras. Hematol. Hemoter"},{"key":"45597_CR8","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1007\/s002770050245","volume":"73","author":"AA Giagounidis","year":"1996","unstructured":"Giagounidis, A. A. et al. Pathologic rupture of the spleen in hematologic malignancies: two additional cases. Ann. Hematol. 73, 297\u2013302 (1996).","journal-title":"Ann. Hematol."},{"key":"45597_CR9","doi-asserted-by":"publisher","first-page":"1114","DOI":"10.1002\/bjs.6737","volume":"96","author":"P Renzulli","year":"2009","unstructured":"Renzulli, P. et al. Systematic review of atraumatic splenic rupture. Br. J. Surg. 96, 1114\u20131121 (2009).","journal-title":"Br. J. Surg."},{"key":"45597_CR10","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1007\/s11912-021-01060-8","volume":"23","author":"OK Weinberg","year":"2021","unstructured":"Weinberg, O. K. & Arber, D. A. Erythroleukemia: an update. Curr. Oncol. Rep. 23, 69 (2021).","journal-title":"Curr. Oncol. Rep."},{"key":"45597_CR11","doi-asserted-by":"crossref","unstructured":"Sharma S, et al. Taurine from tumour niche drives glycolysis to promote leukaemogenesis. Nature. 644, 263-272 (2025).","DOI":"10.1038\/s41586-025-09018-7"},{"key":"45597_CR12","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1038\/s41392-023-01605-2","volume":"8","author":"ZW Huang","year":"2023","unstructured":"Huang, Z. W. et al. STAT5 promotes PD-L1 expression by facilitating histone lactylation to drive immunosuppression in acute myeloid leukemia. Sig Transduct. Target. Ther., 8, 391. (2023).","journal-title":"Sig Transduct. Target. Ther."},{"key":"45597_CR13","doi-asserted-by":"publisher","first-page":"e532","DOI":"10.1038\/cddis.2013.60","volume":"4","author":"Y Zhao","year":"2013","unstructured":"Zhao, Y., Butler, E. B. & Tan, M. Targeting cellular metabolism to improve cancer therapeutics. Cell. Death Dis. 4, e532 (2013).","journal-title":"Cell. Death Dis."},{"key":"45597_CR14","doi-asserted-by":"publisher","first-page":"e82859","DOI":"10.1371\/journal.pone.0082859","volume":"8","author":"S Tiziani","year":"2013","unstructured":"Tiziani, S. et al. Metabolomics of the tumor microenvironment in pediatric acute lymphoblastic leukemia. PLoS One. 8, e82859 (2013).","journal-title":"PLoS One"},{"key":"45597_CR15","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1016\/j.ccell.2016.09.006","volume":"30","author":"W-L Chen","year":"2016","unstructured":"Chen, W-L. et al. Enhanced fructose utilization mediated by SLC2A5 is a unique metabolic feature of acute myeloid leukemia with therapeutic potential. Cancer Cell. 30, 779\u2013791 (2016).","journal-title":"Cancer Cell."},{"key":"45597_CR16","doi-asserted-by":"publisher","first-page":"5382","DOI":"10.1182\/bloodadvances.2023009967","volume":"7","author":"M Rodriguez-Zabala","year":"2023","unstructured":"Rodriguez-Zabala, M. et al. Combined GLUT1 and OXPHOS inhibition eliminates acute myeloid leukemia cells by restraining their metabolic plasticity. Blood Adv. 7, 5382\u20135395 (2023).","journal-title":"Blood Adv."},{"key":"45597_CR17","doi-asserted-by":"publisher","first-page":"119145","DOI":"10.1016\/j.jep.2024.119145","volume":"339","author":"J Song","year":"2025","unstructured":"Song, J. et al. Rocaglamide reprograms glucose metabolism in erythroleukemic cells via c-MYC transcriptional regulation of TXNIP and HK2. J. Ethnopharmacol. 339, 119145 (2025).","journal-title":"J. Ethnopharmacol."},{"key":"45597_CR18","doi-asserted-by":"publisher","first-page":"107963","DOI":"10.1016\/j.bioorg.2024.107963","volume":"153","author":"J Yu","year":"2024","unstructured":"Yu, J. et al. Quinazoline derivatives inhibit cell growth of prostate cancer as a WRN helicase dependent manner by regulating DNA damage repair and microsatellite instability. Bioorg. Chem. 153, 107963 (2024).","journal-title":"Bioorg. Chem."},{"key":"45597_CR19","doi-asserted-by":"publisher","first-page":"117660","DOI":"10.1016\/j.bmc.2024.117660","volume":"102","author":"M Wang","year":"2024","unstructured":"Wang, M. et al. Design, synthesis and antitumor activity of 2-substituted quinazoline-4-amine derivatives. Bioorg. Med. Chem. 102, 117660 (2024).","journal-title":"Bioorg. Med. Chem."},{"key":"45597_CR20","doi-asserted-by":"publisher","first-page":"1967","DOI":"10.4155\/fmc-2023-0151","volume":"15","author":"S Zhang","year":"2023","unstructured":"Zhang, S. et al. Design, synthesis and bioevaluation of novel trifluoromethylquinoline derivatives as tubulin polymerization inhibitors. Future Med. Chem. 15, 1967\u20131986 (2023).","journal-title":"Future Med. Chem."},{"key":"45597_CR21","doi-asserted-by":"publisher","first-page":"115960","DOI":"10.1016\/j.bcp.2023.115960","volume":"219","author":"S Zhang","year":"2024","unstructured":"Zhang, S. et al. A novel L-shaped ortho-quinone analog as PLK1 inhibitor blocks prostate cancer cells in G2 phase. Biochem. Pharmacol. 219, 115960 (2024).","journal-title":"Biochem. Pharmacol."},{"issue":"10","key":"45597_CR22","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1038\/nrd3801","volume":"11","author":"PY Muller","year":"2012","unstructured":"Muller, P. Y. & Milton, M. N. The determination and interpretation of the therapeutic index in drug development. Nat. Rev. Drug Discov. 11 (10), 751\u2013761 (2012).","journal-title":"Nat. Rev. Drug Discov"},{"key":"45597_CR23","doi-asserted-by":"publisher","first-page":"1580","DOI":"10.1016\/j.cmet.2023.07.001","volume":"35","author":"L Wu","year":"2023","unstructured":"Wu, L. et al. Tumor aerobic glycolysis confers immune evasion through modulating sensitivity to T cell-mediated bystander killing via TNF\u03b1. Cell. Metab. 35, 1580\u20131596 (2023).","journal-title":"Cell. Metab."},{"key":"45597_CR24","doi-asserted-by":"publisher","first-page":"908","DOI":"10.1101\/gad.5.6.908","volume":"5","author":"Y Ben-David","year":"1991","unstructured":"Ben-David, Y. et al. Erythroleukemia induction by Friend murine leukemia virus: insertional activation of a new member of the ets gene family, Fli-1, closely linked to c-ets-1. Genes Dev. 5, 908\u2013918 (1991).","journal-title":"Genes Dev."},{"issue":"3","key":"45597_CR25","doi-asserted-by":"publisher","first-page":"99","DOI":"10.2144\/btn-2022-0034","volume":"75","author":"R Sule","year":"2023","unstructured":"Sule, R., Rivera, G. & Gomes, A. V. Western blotting (immunoblotting): history, theory, uses, protocol and problems. Biotechniques 75 (3), 99\u2013114 (2023).","journal-title":"Biotechniques"},{"key":"45597_CR26","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1038\/nrc.2016.77","volume":"16","author":"N Hay","year":"2016","unstructured":"Hay, N. Reprogramming glucose metabolism in cancer: can it be exploited for cancer therapy? Nat. Rev. Cancer. 16, 635\u2013649 (2016).","journal-title":"Nat. Rev. Cancer"},{"key":"45597_CR27","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1016\/j.metabol.2015.10.007","volume":"65","author":"CC Barron","year":"2016","unstructured":"Barron, C. C., Bilan, P. J., Tsakiridisc, T. & Tsiani, E. Facilitative glucose transporters: implications for cancer detection, prognosis and treatment. Metabolism 65, 124\u2013139 (2016).","journal-title":"Metabolism"},{"key":"45597_CR28","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1016\/j.ijbiomac.2022.07.123","volume":"216","author":"X Chen","year":"2022","unstructured":"Chen, X. et al. Identification of a novel GLUT1 inhibitor with in vitro and in vivo anti-tumor activity. Inte J. Biol. Macromol. 216, 768\u2013788 (2022).","journal-title":"Inte J. Biol. Macromol."},{"key":"45597_CR29","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1021\/acs.jmedchem.4c02717","volume":"68","author":"Y Wang","year":"2025","unstructured":"Wang, Y. et al. Recent progress in the development of glucose transporter (GLUT) inhibitors. J. Med. Chem. 68, 1033\u20131050 (2025).","journal-title":"J. Med. Chem."},{"key":"45597_CR30","doi-asserted-by":"publisher","first-page":"14233","DOI":"10.1021\/acsnano.5c00730","volume":"19","author":"M Zhang","year":"2025","unstructured":"Zhang, M. et al. Synchronously evoking disulfidptosis and ferroptosis via systematical glucose deprivation targeting SLC7A11\/GSH\/GPX4 antioxidant axis. ACS Nano. 19, 14233\u201314248 (2025).","journal-title":"ACS Nano"},{"key":"45597_CR31","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1038\/s41577-024-01026-4","volume":"24","author":"M De Martino","year":"2024","unstructured":"De Martino, M. et al. Cancer cell metabolism and antitumour immunity. Nat. Rev. Immunol. 24, 654\u2013669 (2024).","journal-title":"Nat. Rev. Immunol."},{"key":"45597_CR32","doi-asserted-by":"publisher","first-page":"7021","DOI":"10.1038\/s41467-023-42883-2","volume":"14","author":"X Ren","year":"2023","unstructured":"Ren, X. et al. Inhibition of glycolysis-driven immunosuppression with a nano-assembly enhances response to immune checkpoint blockade therapy in triple negative breast cancer. Nat. Commun. 14, 7021 (2023).","journal-title":"Nat. Commun."},{"key":"45597_CR33","doi-asserted-by":"publisher","first-page":"149352","DOI":"10.1016\/j.gene.2025.149352","volume":"948","author":"M Agrawal","year":"2025","unstructured":"Agrawal, M. et al. Overcoming drug resistance in ovarian cancer through PI3K\/AKT signaling inhibitors. Gene 948, 149352 (2025).","journal-title":"Gene"},{"key":"45597_CR34","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1038\/s41388-024-03224-9","volume":"44","author":"C Lyu","year":"2025","unstructured":"Lyu, C. et al. Unveiling RACK1: a key regulator of the PI3K\/AKT pathway in prostate cancer development. Oncogene 44, 322\u2013335 (2025).","journal-title":"Oncogene"},{"key":"45597_CR35","doi-asserted-by":"publisher","first-page":"119126","DOI":"10.1016\/j.jep.2024.119126","volume":"338","author":"J Zhou","year":"2025","unstructured":"Zhou, J. et al. Chrysotoxine regulates ferroptosis and the PI3K\/AKT\/mTOR pathway to prevent cervical cancer. J. Ethnopharmacol. 338, 119126 (2025).","journal-title":"J. Ethnopharmacol."},{"key":"45597_CR36","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1038\/s41419-025-07559-3","volume":"16","author":"W Mei","year":"2025","unstructured":"Mei, W. et al. BCAT2 binding to PCBP1 regulates the PI3K\/AKT signaling pathway to inhibit autophagy-related apoptosis and ferroptosis in prostate cancer. Cell. Death Dis. 16, 337 (2025).","journal-title":"Cell. Death Dis."},{"key":"45597_CR37","doi-asserted-by":"publisher","first-page":"3113","DOI":"10.7150\/ijbs.89942","volume":"20","author":"F Fontana","year":"2024","unstructured":"Fontana, F. et al. The PI3K\/Akt pathway and glucose metabolism: a dangerous liaison in cancer. Int. J. Biol. Sci. 20, 3113\u20133125 (2024).","journal-title":"Int. J. Biol. Sci."},{"key":"45597_CR38","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1038\/s41568-019-0216-7","volume":"20","author":"G Hoxhaj","year":"2020","unstructured":"Hoxhaj, G. & Manning, B. D. The PI3K\u2013AKT network at the interface of oncogenic signalling and cancer metabolism. Nat. Rev. Cancer. 20, 74\u201388 (2020).","journal-title":"Nat. Rev. Cancer"},{"key":"45597_CR39","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1038\/s41388-024-02959-9","volume":"43","author":"L Shi","year":"2024","unstructured":"Shi, L. et al. TMEM65 promotes gastric tumorigenesis by targeting YWHAZ to activate PI3K-Akt-mTOR pathway and is a therapeutic target. Oncogene 43, 931\u2013943 (2024).","journal-title":"Oncogene"},{"issue":"4","key":"45597_CR40","doi-asserted-by":"publisher","first-page":"1002","DOI":"10.1158\/2159-8290.CD-22-0805","volume":"13","author":"BD Stein","year":"2023","unstructured":"Stein, B. D. et al. LKB1-dependent regulation of TPI1 creates a divergent metabolic liability between human and mouse lung adenocarcinoma. Cancer Discov. 13 (4), 1002\u20131025 (2023).","journal-title":"Cancer Discov"},{"issue":"1","key":"45597_CR41","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/j.cmet.2023.12.003","volume":"36","author":"Y Zhang","year":"2024","unstructured":"Zhang, Y. et al. Metabolic switch regulates lineage plasticity and induces synthetic lethality in triple-negative breast cancer. Cell. Metab. 36 (1), 193\u2013208e8 (2024).","journal-title":"Cell. Metab."},{"issue":"1","key":"45597_CR42","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1007\/s10555-024-10170-1","volume":"43","author":"R Vishwa","year":"2024","unstructured":"Vishwa, R. et al. Lipid metabolism and its implications in tumor cell plasticity and drug resistance: what we learned thus far? Cancer Metastasis Rev. 43 (1), 293\u2013319 (2024).","journal-title":"Cancer Metastasis Rev."},{"key":"45597_CR43","doi-asserted-by":"publisher","first-page":"792","DOI":"10.3389\/fonc.2020.00792","volume":"10","author":"NY Sun","year":"2020","unstructured":"Sun, N. Y. & Yang, M. H. Metabolic reprogramming and epithelial-mesenchymal plasticity: opportunities and challenges for cancer therapy. Front. Oncol. 10, 792 (2020).","journal-title":"Front. Oncol."},{"issue":"1","key":"45597_CR44","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1186\/s12943-024-02119-3","volume":"23","author":"M Tufail","year":"2024","unstructured":"Tufail, M., Jiang, C. H. & Li, N. Altered metabolism in cancer: insights into energy pathways and therapeutic targets. Mol. Cancer. 23 (1), 203 (2024).","journal-title":"Mol. Cancer"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-45597-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-45597-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-45597-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T23:12:15Z","timestamp":1774998735000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-45597-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,27]]},"references-count":44,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["45597"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-45597-9","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,27]]},"assertion":[{"value":"25 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The Animal Ethics Committee of the Guizhou Medical University approved all animal experiments on July 12, 2024 (No.2403165). All experiments involving animals were conducted in strict compliance with the Guide for the Care and Use of Laboratory Animals (8th edition, National Academies Press, 2011) and the ARRIVE Guidelines 2.0.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical statement"}},{"value":"Written informed consent for publication was obtained from all participants.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}],"article-number":"10916"}}